Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation

Jae Jin Kwak, Hui Nam Pak, Jin Kun Jang, Sook Kyoung Kim, Jae Hyung Park, Jongil Choi, Chun Hwang, Young Hoon Kim

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Continuous Warfarin Before AF Ablation. Background: We investigated the efficiency and convenience of a continuous warfarinization (CW) strategy during the periprocedural period of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) in comparison with the classic strategy of switching to heparin (SH). Methods and Results: We compared CW (n = 49) and SH (n = 55, 3 days before RFCA) in 104 patients who underwent RFCA of AF (77 males, 55 ± 12 years old, paroxysmal AF: persistent AF = 63:41). During the procedure, the activated clotting time (ACT) was maintained between 350 and 400 seconds, and a requirement of H, postablation INR, and periprocedural complications were compared. Results were as follows: (1) in the CW group, the preprocedural INR (1.85 ± 0.61 vs 1.05 ± 0.12, P < 0.001) and the proportions of INR > 2.0 after RFCA (1st postprocedure day 61.2% vs 5.5%, P < 0.001; 2nd postprocedure day 83.3% vs 21.8%, P < 0.005) were higher, and the heparin requirement was lower (2012 ± 998 U/30 minutes vs 2921 ± 795 U/30 minutes, P < 0.001) than in the SH group. (2) The incidences of hemorrhagic complications (18.2% vs 18.4%, P = NS) or the major bleeding rates (reduced hemoglobin ≥ 4 g/dL, requiring blood transfusion; 3.6% vs 12.2%, P = NS) were not significantly different in the CW group than in the SH group. Conclusion: The periprocedural CW strategy maintains a more stable INR immediately after AF ablation without increasing hemorrhagic complications compared with the classic strategy of SH. Simple CW can replace SH in an experienced laboratory with a low risk of hemopericardium during AF ablation.

Original languageEnglish
Pages (from-to)620-625
Number of pages6
JournalJournal of Cardiovascular Electrophysiology
Volume21
Issue number6
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Catheter Ablation
Warfarin
Atrial Fibrillation
Heparin
Safety
International Normalized Ratio
Pericardial Effusion
Blood Transfusion
Hemoglobins
Hemorrhage
Incidence

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Catheter ablation
  • Heparin
  • Warfarin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. / Kwak, Jae Jin; Pak, Hui Nam; Jang, Jin Kun; Kim, Sook Kyoung; Park, Jae Hyung; Choi, Jongil; Hwang, Chun; Kim, Young Hoon.

In: Journal of Cardiovascular Electrophysiology, Vol. 21, No. 6, 01.01.2010, p. 620-625.

Research output: Contribution to journalArticle

@article{c7d5d36e31d944b6aa4c37a5dbb447d3,
title = "Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation",
abstract = "Continuous Warfarin Before AF Ablation. Background: We investigated the efficiency and convenience of a continuous warfarinization (CW) strategy during the periprocedural period of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) in comparison with the classic strategy of switching to heparin (SH). Methods and Results: We compared CW (n = 49) and SH (n = 55, 3 days before RFCA) in 104 patients who underwent RFCA of AF (77 males, 55 ± 12 years old, paroxysmal AF: persistent AF = 63:41). During the procedure, the activated clotting time (ACT) was maintained between 350 and 400 seconds, and a requirement of H, postablation INR, and periprocedural complications were compared. Results were as follows: (1) in the CW group, the preprocedural INR (1.85 ± 0.61 vs 1.05 ± 0.12, P < 0.001) and the proportions of INR > 2.0 after RFCA (1st postprocedure day 61.2{\%} vs 5.5{\%}, P < 0.001; 2nd postprocedure day 83.3{\%} vs 21.8{\%}, P < 0.005) were higher, and the heparin requirement was lower (2012 ± 998 U/30 minutes vs 2921 ± 795 U/30 minutes, P < 0.001) than in the SH group. (2) The incidences of hemorrhagic complications (18.2{\%} vs 18.4{\%}, P = NS) or the major bleeding rates (reduced hemoglobin ≥ 4 g/dL, requiring blood transfusion; 3.6{\%} vs 12.2{\%}, P = NS) were not significantly different in the CW group than in the SH group. Conclusion: The periprocedural CW strategy maintains a more stable INR immediately after AF ablation without increasing hemorrhagic complications compared with the classic strategy of SH. Simple CW can replace SH in an experienced laboratory with a low risk of hemopericardium during AF ablation.",
keywords = "Anticoagulation, Atrial fibrillation, Catheter ablation, Heparin, Warfarin",
author = "Kwak, {Jae Jin} and Pak, {Hui Nam} and Jang, {Jin Kun} and Kim, {Sook Kyoung} and Park, {Jae Hyung} and Jongil Choi and Chun Hwang and Kim, {Young Hoon}",
year = "2010",
month = "1",
day = "1",
doi = "10.1111/j.1540-8167.2009.01670.x",
language = "English",
volume = "21",
pages = "620--625",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation

AU - Kwak, Jae Jin

AU - Pak, Hui Nam

AU - Jang, Jin Kun

AU - Kim, Sook Kyoung

AU - Park, Jae Hyung

AU - Choi, Jongil

AU - Hwang, Chun

AU - Kim, Young Hoon

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Continuous Warfarin Before AF Ablation. Background: We investigated the efficiency and convenience of a continuous warfarinization (CW) strategy during the periprocedural period of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) in comparison with the classic strategy of switching to heparin (SH). Methods and Results: We compared CW (n = 49) and SH (n = 55, 3 days before RFCA) in 104 patients who underwent RFCA of AF (77 males, 55 ± 12 years old, paroxysmal AF: persistent AF = 63:41). During the procedure, the activated clotting time (ACT) was maintained between 350 and 400 seconds, and a requirement of H, postablation INR, and periprocedural complications were compared. Results were as follows: (1) in the CW group, the preprocedural INR (1.85 ± 0.61 vs 1.05 ± 0.12, P < 0.001) and the proportions of INR > 2.0 after RFCA (1st postprocedure day 61.2% vs 5.5%, P < 0.001; 2nd postprocedure day 83.3% vs 21.8%, P < 0.005) were higher, and the heparin requirement was lower (2012 ± 998 U/30 minutes vs 2921 ± 795 U/30 minutes, P < 0.001) than in the SH group. (2) The incidences of hemorrhagic complications (18.2% vs 18.4%, P = NS) or the major bleeding rates (reduced hemoglobin ≥ 4 g/dL, requiring blood transfusion; 3.6% vs 12.2%, P = NS) were not significantly different in the CW group than in the SH group. Conclusion: The periprocedural CW strategy maintains a more stable INR immediately after AF ablation without increasing hemorrhagic complications compared with the classic strategy of SH. Simple CW can replace SH in an experienced laboratory with a low risk of hemopericardium during AF ablation.

AB - Continuous Warfarin Before AF Ablation. Background: We investigated the efficiency and convenience of a continuous warfarinization (CW) strategy during the periprocedural period of radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) in comparison with the classic strategy of switching to heparin (SH). Methods and Results: We compared CW (n = 49) and SH (n = 55, 3 days before RFCA) in 104 patients who underwent RFCA of AF (77 males, 55 ± 12 years old, paroxysmal AF: persistent AF = 63:41). During the procedure, the activated clotting time (ACT) was maintained between 350 and 400 seconds, and a requirement of H, postablation INR, and periprocedural complications were compared. Results were as follows: (1) in the CW group, the preprocedural INR (1.85 ± 0.61 vs 1.05 ± 0.12, P < 0.001) and the proportions of INR > 2.0 after RFCA (1st postprocedure day 61.2% vs 5.5%, P < 0.001; 2nd postprocedure day 83.3% vs 21.8%, P < 0.005) were higher, and the heparin requirement was lower (2012 ± 998 U/30 minutes vs 2921 ± 795 U/30 minutes, P < 0.001) than in the SH group. (2) The incidences of hemorrhagic complications (18.2% vs 18.4%, P = NS) or the major bleeding rates (reduced hemoglobin ≥ 4 g/dL, requiring blood transfusion; 3.6% vs 12.2%, P = NS) were not significantly different in the CW group than in the SH group. Conclusion: The periprocedural CW strategy maintains a more stable INR immediately after AF ablation without increasing hemorrhagic complications compared with the classic strategy of SH. Simple CW can replace SH in an experienced laboratory with a low risk of hemopericardium during AF ablation.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Catheter ablation

KW - Heparin

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=77952592945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952592945&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.2009.01670.x

DO - 10.1111/j.1540-8167.2009.01670.x

M3 - Article

VL - 21

SP - 620

EP - 625

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 6

ER -